Warning letter
Morton Drug Company dba Morton LTC: warning letter of Oct 26, 2016
FDA warning letter 496920 · Minneapolis District Office
Key facts
| Reference number | 496920 |
|---|---|
| Company | Morton Drug Company dba Morton LTC |
| Subject | Drug/Prepared, Packed or Held Under Insanitary Conditions/Adulterated |
| Issue date | Oct 26, 2016 |
| Posted date | Nov 14, 2016 |
| Issuing office | Minneapolis District Office |
| Product type | Drugs |
| Inspection city | Neenah |
| Inspection ZIP | 54956 |
| Inspection start date | Dec 15, 2015 |
| Letter on fda.gov | web.archive.org |
At a glance
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: